Your session is about to expire
← Back to Search
Cannabinoid
THC for Cannabis Effects (THC-Gender Trial)
Phase 1
Recruiting
Research Sponsored by Yale University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Must not have
Taking estrogen supplements or oral contraceptive pills (for women)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 25 minutes after thc infusion begins
Summary
This trial will study how men and women differ in their reaction to marijuana.
Who is the study for?
This trial is for people who have tried cannabis at least once and are in good physical and mental health. Women can't join if they're taking estrogen supplements or birth control pills, and it's not for anyone who has never used cannabis or those dealing with major stress recently.
What is being tested?
The study is looking into how THC (the active component of cannabis) affects men and women differently when taken acutely. Participants will receive either THC or a placebo to compare the immediate effects between genders.
What are the potential side effects?
THC may cause short-term side effects such as altered senses, changes in mood, impaired body movement, difficulty with thinking and problem-solving, impaired memory, hallucinations, delusions, or psychosis.
Eligibility Criteria
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am currently taking estrogen supplements or oral contraceptive pills.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 25 minutes after thc infusion begins
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~25 minutes after thc infusion begins
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Rewarding Effects measured by Visual Analog Scale (VAS)
Verbal Learning: measured by Rey Auditory Verbal Learning Test (AVLT)
Trial Design
2Treatment groups
Active Control
Placebo Group
Group I: THCActive Control1 Intervention
Active THC (0.015mg/kg) administered intravenously over 10 minutes.
Group II: PlaceboPlacebo Group1 Intervention
Control: small amount of alcohol intravenously (quarter teaspoon), with no THC over 10 minutes.
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Yale UniversityLead Sponsor
1,930 Previous Clinical Trials
3,033,358 Total Patients Enrolled
14 Trials studying Cannabis
659 Patients Enrolled for Cannabis
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am in good physical and mental health.I am currently taking estrogen supplements or oral contraceptive pills.
Research Study Groups:
This trial has the following groups:- Group 1: THC
- Group 2: Placebo
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.